Sanders Morris Harris’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,250	Closed	-$22.2K	–	159
2025 Q3	$22.2K	Buy	+10,250	New	+$24.2K	﹤0.01%	301
2025 Q2	–	Sell	-10,250	Closed	-$33.3K	–	227
2025 Q1	$33.3K	Hold	10,250	–	–	0.01%	277
2024 Q4	$75.8K	Sell	10,250 -5,950	-37%	-$55.2K	0.01%	276
2024 Q3	$152K	Hold	16,200	–	–	0.03%	262
2024 Q2	$130K	Hold	16,200	–	–	0.02%	260
2024 Q1	$240K	Hold	16,200	–	–	0.04%	228
2023 Q4	$152K	Hold	16,200	–	–	0.07%	159
2023 Q3	$71.6K	Hold	16,200	–	–	0.01%	246
2023 Q2	$115K	Buy	+16,200	New	+$116K	0.03%	239
2023 Q1	–	Sell	-16,200	Closed	-$104K	–	198
2022 Q4	$104K	Hold	16,200	–	–	0.04%	191
2022 Q3	$152K	Hold	16,200	–	–	0.04%	254
2022 Q2	$186K	Sell	16,200 -16,200	-50%	-$212K	0.04%	257
2022 Q1	$539K	Buy	32,400 +16,200	+100%	+$251K	0.11%	154
2021 Q4	$310K	Hold	16,200	–	–	0.05%	231
2021 Q3	$433K	Hold	16,200	–	–	0.08%	188
2021 Q2	$415K	Hold	16,200	–	–	0.08%	199
2021 Q1	$502K	Hold	16,200	–	–	0.11%	155
2020 Q4	$820K	Hold	16,200	–	–	0.19%	100
2020 Q3	$518K	Buy	+16,200	New	+$497K	0.14%	138